Cases & Deals

Celgene develops global patent portfolio for agonistic anti-PD1 antibody therapeutics

Clients Celgene Corporation

Jones Day represents Celgene Corporation in the establishment of a global patent portfolio related to agonistic anti-PD1 therapeutic antibodies.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.